Abstract:Three new Co(II) complexes, [Co4(L)2(μ3-CrO4)2](ClO4)2·2CH3CN (1), [Co2(L)(μ2-na)(H2O)](ClO4)2 (2) and [Co2(L)(μ2-ba)](ClO4)2·0.5CH3CN (3) (Hna=nicotinic acid, Hba=benzoic acid, HL=N,N,N',N'-tetrakis (2-quinolylmethyl)-1,3-diaminopropan-2-ol), have been synthesized and characterized by various physicochemical techniques. The Co(II) centers are connected by endogenous alkoxy bridge from L(-) and various extrinsic auxiliary linkers, some of which display coordination number asymmetry (5, 6-coordinated for 1 and 2; 5, 5-coordinated for 3). It is worth mentioning that complex 1 contains two rare reported μ3-η(1), η(1), η(1)-CrO4(2-) moieties. Susceptibility data of three complexes indicated intramolecular antiferromagnetic coupling of high-spin Co(II) atoms with exchange integral values (J) -14.94 cm(-1), -11.26 cm(-1) and -13.66 cm(-1) for 1, 2 and 3, respectively. Interaction of compounds with calf thymus DNA (CT-DNA) have been investigated by absorption spectral titration, ethidium bromide (EB) displacement assay and viscosity measurement, which revealed that compounds bound to CT-DNA with a moderate intercalative mode, accompanied the affinities order: 1>2≈3. Three complexes exhibit oxidative cleavage of pBR322 plasmid DNA including a reliance on H2O2 as the activator. Compound 1 demonstrates an increased DNA cleavage activity as compared with 2 and 3, which could degrade super coiled DNA (SC DNA) into nicked coiled DNA (NC DNA) in lower concentration (5 μM). Moreover, all compounds could quench the intrinsic fluorescence of bovine serum albumin (BSA) in a static quenching process. Complex 1 also shows higher anticancer activity than cisplatin with lower IC50 value of incubation for both 24 h and 48 h.

Synthesis and properties of K(I)/Co(II) complexes with (18-crown-6) disalophen and its substituted derivatives

Cobalt(II) complexes bearing 2-imino-1,10-phenanthroline ligands: synthesis, characterization and ethylene oligomerization

Bis(1h-Imidazole-Kappa N-3)Bis(2-Oxidopyridinium-3-Carboxylato-Kappa O-2(2),O-3)Cobalt(Ii)

Bis(1H-imidazole-κN)bis-(2-oxidopyridinium-3-carboxyl-ato-κO,O)cobalt(II).

Bis(1H-imidazole-&#954;N3)bis(2-oxidopyridinium-3-carboxylato-&#954;2O2,O3)cobalt(II)

Diaquabis(4-hydroxybenzoato-κO)(1,10-phenanthroline-κ2N,N′)cobalt(II) Monohydrate

Tetrakis(Benzimidazole-Kappa N)(Malonato-Kappa O-2,O ')Cobalt(Ii)

Synthesis, Structure and Property of Cobalt(ii) Complexes with 3,5-Di(1h-imidazol-1-yl)benzoic Acid

Stability studies on 12-(5′-8′- hydroxyquinolinic)methylene-1,4,7,10-tetraazacyclo tridecane-11,13-dione, 5-substituted 1,10-phenanthroline-copper(II) with Cu2+ or Co2+ binuclear mixed-coordinated systems

Synthesis, structure, and ion-binding studies of cobalt(II) complexes with aza-crown substituted salicylaldimine Schiff base ligand

Studies on stabilities of 6-(5′-8′-hydroxyquinolinic)methylene-1,4,8,11-tetraazacyclo tetradecane-5,7-dione, 5-substituted 1,10-phenanthroline-copper(II) with Cu2+ or Co2+ binuclear mixed-coordinated systems

Cobalt and nickel complexes bearing 2,6-bis (imino) phenoxy ligands: syntheses, structures and oligomerization studies

A Mixed-Valent High Spin (Μ-Hydroxo)dicobalt(ii/iii) Complex and Its End-on Type Dioxygen Adduct: Synthesis, Geometric and Electronic Structure Studies

Kinetic and Equilibrium Studies of the Acid Dissociation of the Cobalt(Ii) Complexes of N,N '-Dialkyl-1,10-phenanthroline-2,9-dimathanamine Ligands

Synthesis and Characterization of 2,6-Bis(imino)phenoxy Cobalt Complexes

Synthesis of a potassium capped terminal cobalt–oxido complex

Synthesis and Properties of Cobalt Complexes with [B 11 H 11 ] 4- Ligands

Cobalt Cyclopentadienyl-Phosphine Dinitrogen Complexes.

Bio-relevant Cobalt(ii) Complexes with Compartmental Polyquinoline Ligand: Synthesis, Crystal Structures and Biological Activities.

Cobalt complexes with pnicogen (phosphine or pyridine) and thiolato ligands. Syntheses, x-ray crystal structures and spectroscopic characterization

Synthesis and Crystal Structure of Cobalt(II) and Cadmium(II) Complexes with the Flexible Tripodal Ligand 1,3,5‐Tris(4‐pyridylmethoxyl)benzene